Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TOnado 1: tiotropium + olodaterol fixed-dose combination versus components in COPD
NL-OMON35802Phase 3Active, not recruiting
- Sponsor
- Boehringer Ingelheim
- Start
- Oct 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of tiotropium, olodaterol in chronic obstructive pulmonary disease (COPD), sponsored by Boehringer Ingelheim. Started Oct 2011; status: active, not recruiting.
02
Drugs
tiotropiumolodaterol
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NL-OMON35802.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON35802.